Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
Abstract
Preliminary trial results showed that enzalutamide significantly improved metastasis-free survival among men who had nonmetastatic, castration-resistant prostate cancer and rapidly increasing prostate-specific antigen (PSA) levels while taking androgen-deprivation therapy. Results from the final analysis of overall survival have not yet been...
Paper Details
Title
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
Published Date
Jun 4, 2020
Volume
382
Issue
23
Pages
2197 - 2206
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History